Item
Moderna is Developing Two New Vaccines-- And One Could Protect Against the Common Cold
Title (Dublin Core)
Moderna is Developing Two New Vaccines-- And One Could Protect Against the Common Cold
Description (Dublin Core)
This is a news story by health.com written by Alyssa Hui. This story is about Moderna expanding its biotechnology into creating new vaccines using similar techniques the COVID vaccines have used. One of these vaccines will be used to help combat RSV, which is a virus that hospitalizes an average of 177,000 adults per year, according to the CDC.
Another illness that Moderna is looking to use vaccines against are four other endemic human coronaviruses. Moderna does not claim they offer 100% guaranteed protection, but that they can benefit people greatly for reducing chances of contracting certain illnesses.
Moderna wants to ensure that the vaccines are safe and will go through testing procedures to do so. They are hoping that there will be more uses for mRNA style vaccines in the future, and not just for the coronavirus.
Another illness that Moderna is looking to use vaccines against are four other endemic human coronaviruses. Moderna does not claim they offer 100% guaranteed protection, but that they can benefit people greatly for reducing chances of contracting certain illnesses.
Moderna wants to ensure that the vaccines are safe and will go through testing procedures to do so. They are hoping that there will be more uses for mRNA style vaccines in the future, and not just for the coronavirus.
Date (Dublin Core)
April 15, 2022
Creator (Dublin Core)
Alyssa Hui
Event Identifier (Dublin Core)
HST580
Partner (Dublin Core)
Arizona State University
Type (Dublin Core)
Text story
Link (Bibliographic Ontology)
Controlled Vocabulary (Dublin Core)
English
News coverage
English
Science
English
Healthcare
Curator's Tags (Omeka Classic)
Centers for Disease Control and Prevention
mRNA
vaccine
Respiratory Illnesses
research
HCoVs
Contributor's Tags (a true folksonomy) (Friend of a Friend)
Moderna
common cold
RSV
mRNA
science
vaccine
Linked Data (Dublin Core)
Date Submitted (Dublin Core)
04/16/2022
Date Modified (Dublin Core)
04/18/2022
04/26/2022
04/28/2022
08/02/2022
Item sets
This item was submitted on April 16, 2022 by [anonymous user] using the form “Share Your Story” on the site “A Journal of the Plague Year”: http://mail.covid-19archive.org/s/archive
Click here to view the collected data.